Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB

Conclusion: As a blood-pool imaging agent, 68Ga-NEB is safe to use in the clinic, and our preliminary studies demonstrate the value of differentiating hepatic hemangioma from other benign or malignant focal hepatic lesions. Easy labeling with different positron emitters of various half-lives, excellent pharmacokinetics, and imaging quality warrant further clinical applications of NEB-based PET tracers.

Source: Journal of Nuclear Medicine - October 1, 2015 Category: Nuclear Medicine Authors: Zhang, J., Lang, L., Zhu, Z., Li, F., Niu, G., Chen, X. Tags: Basic Science Investigations Source Type: research